MedPath
FDA Approval

Sufentanil Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 11, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sufentanil(0.05 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Hikma Pharmaceuticals USA Inc.

West-Ward Pharmaceuticals Corp.

946499746

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sufentanil Citrate

Product Details

NDC Product Code
0641-6110
Application Number
ANDA074413
Marketing Category
ANDA (C73584)
Route of Administration
EPIDURAL, INTRAVENOUS
Effective Date
September 17, 2018
WATERInactive
Code: 059QF0KO0RClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: S9ZFX8403RClass: ACTIMQuantity: 0.05 mg in 1 mL

Sufentanil Citrate

Product Details

NDC Product Code
0641-6112
Application Number
ANDA074413
Marketing Category
ANDA (C73584)
Route of Administration
EPIDURAL, INTRAVENOUS
Effective Date
September 17, 2018
Code: S9ZFX8403RClass: ACTIMQuantity: 0.05 mg in 1 mL
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT

Sufentanil Citrate

Product Details

NDC Product Code
0641-6111
Application Number
ANDA074413
Marketing Category
ANDA (C73584)
Route of Administration
EPIDURAL, INTRAVENOUS
Effective Date
September 17, 2018
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: S9ZFX8403RClass: ACTIMQuantity: 0.05 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath